Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells-Reference-Cited by-同舟云学术

Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells

Published:2019-01-28 Issue:6 Volume:6 Page:1802062
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Lin Abraham¹²^ORCID,Gorbanev Yury¹,De Backer Joey³,Van Loenhout Jinthe²,Van Boxem Wilma¹,Lemière Filip⁴,Cos Paul⁵,Dewilde Sylvia³,Smits Evelien²,Bogaerts Annemie¹

Affiliation:

1. Plasma, Laser Ablation, and Surface Modeling—Antwerp (PLASMANT)University of Antwerp Universiteitsplein 1 2610 Antwerpen‐Wilrijk Belgium

2. Center for Oncological Research (CORE)University of Antwerp Universiteitsplein 1 2610 Antwerpen‐Wilrijk Belgium

3. Department of Biomedical SciencesUniversity of Antwerp Universiteitsplein 1 2610 Antwerpen‐Wilrijk Belgium

4. Biomolecular and Analytical Mass Spectrometry (BAMS) GroupDepartment of Chemistry & Centre for ProteomicsUniversity of Antwerp Groenenborgerlaan 171 2020 Antwerpen Belgium

5. Department of Pharmaceutical SciencesUniversity of Antwerp Universiteitsplein 1 2610 Antwerpen‐Wilrijk Belgium

Funder

Flanders Research Foundation

European Marie Sklodowska-Curie Individual Fellowship within Horizon2020

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201802062

Reference48 articles.

1. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3. Oncology Meets Immunology: The Cancer-Immunity Cycle

4. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

5. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-11

2. Synergetic Sonodynamic-Immunotherapy based on phycocyanin nanoparticles (PCNP) reduces tumor growth and metastasis in mice;Chemical Engineering Journal;2024-10

3. Preparation of a Plasma‐Induced Dendritic Cell Vaccine and its Anti‐Tumor Immunity in a Murine Model of Melanoma;Advanced Therapeutics;2024-09-09

4. Nonthermal plasma processing catalyzed by CuFe2O4 for organic pollutants remediation and bacterial inactivation with density functional theory;Chemosphere;2024-08

5. Enhancement of Biocompatibility of High-Transparency Zirconia Abutments with Human Gingival Fibroblasts via Cold Atmospheric Plasma Treatment: An In Vitro Study;Journal of Functional Biomaterials;2024-07-21